NCT02782845 An Expanded Access Program of Pegfilgrastim (Neulastim) in Participants With Non-Hodgkin's Lymphoma (NHL) Status COMPLETED Phase PHASE4
NCT02753036 Chemotherapy-induced Cognitive Alterations in Recruits With Ovarian and Breast Cancer Status UNKNOWN Phase N/A
NCT02738606 Liver Surgery and Chemotherapy in Treating Patients With Colorectal Cancer With Liver Metastases That Can Be Removed by Surgery and Lung Metastases That Cannot Be Removed by Surgery Status TERMINATED Phase PHASE2
NCT02728622 Chemotherapy vs Hormonal Treatment in Platinum-resistant Ovarian Cancer Resistant or Refractory to Platinum and Taxane Status COMPLETED Phase PHASE3
NCT02679040 Histological Response Rate After Mastectomy and Immediate Breast Reconstruction at the End of Neoadjuvant Chemotherapy and Radiotherapy Status UNKNOWN Phase PHASE2
NCT02671890 Disulfiram and Chemotherapy in Treating Patients With Refractory Solid Tumors or Metastatic Pancreatic Cancer Status TERMINATED Phase PHASE1
NCT02668653 Quizartinib With Standard of Care Chemotherapy and as Continuation Therapy in Patients With Newly Diagnosed FLT3-ITD (+) Acute Myeloid Leukemia (AML) Status COMPLETED Phase PHASE3
NCT02634645 TREAT-BE Study (Treatment With Resection and Endoscopic Ablation Techniques for Barrett's Esophagus) Status RECRUITING Phase N/A
NCT02621333 Chemotherapy Combined Autologous Cytokine-induced Killer Cells in Naive Stage IV EGFR-wild Type Lung Adenocarcinoma Status TERMINATED Phase PHASE2
NCT02620423 Study of Pembrolizumab With REOLYSIN® and Chemotherapy in Patients With Advanced Pancreatic Adenocarcinoma Status COMPLETED Phase PHASE1
NCT02528175 Magnetic Resonance-Guided High Intensity Focused Ultrasound for Recurrent Rectal Cancer Status COMPLETED Phase NA
NCT02503150 Trial of Antigen Pulsed Dendritic Cells (APDC) in Metastatic Colorectal Cancer Status UNKNOWN Phase PHASE3
NCT02472756 A Study of Rituximab in Combination With Chemotherapy in Relapsed/Refractory Follicular Lymphoma Status COMPLETED Phase N/A
NCT02448797 Icotinib as Adjuvant Therapy Compared With Standard Chemotherapy in Stage II-IIIA NSCLC With EGFR-mutation Status UNKNOWN Phase PHASE3
NCT02448420 Study of Palbociclib and Trastuzumab With Endocrine Therapy in HER2-positive Metastatic Breast Cancer Status COMPLETED Phase PHASE2
NCT02405078 Tumor-Specific Clonotype, Metabolic Profile, and PET/CT in Predicting Chemotherapy Response in Patients With Relapsed or Refractory Diffuse Large B-cell Lymphoma Status COMPLETED Phase EARLY_PHASE1
NCT02392429 FLT PET/CT in Measuring Response in Patients With Previously Untreated Acute Myeloid Leukemia Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT02363049 Colectomy in Patients With Asymptomatic and Unresectable Stage IV Colon Cancer Status UNKNOWN Phase PHASE3